Genomika Lietuva is a business that provides cutting-edge, perceptive, and meticulously optimized solutions for the biomedical sciences.
Genomika has raised $5.5M in total funding. The most recent round was Grant. The last funding was announced in July 2023.
Genomika's investors include European Innovation Council.
Genomika is headquartered in Kaunas, Lithuania.
Genomika Lietuva is a business that provides cutting-edge, perceptive, and meticulously optimized solutions for the biomedical sciences.
Genomika is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genomika — Funding & Investors." VCBacked, July 31, 2023, https://www.vcbacked.co/company/genomika. Accessed September 14, 2026.
VCBacked. (2023). Genomika — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/genomika
{{cite web |title=Genomika — Funding & Investors |url=https://www.vcbacked.co/company/genomika |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated